广西壮族自治区HIV—1流行毒株的基因序列测定和亚型分析

使用ＰＣＲ技术对１４份广西ＨＩＶ－１阳性感染者外周血单核细胞（ＰＢＭＣｓ）样品进行扩增,获得ＨＩＶ－１膜蛋白（ｅｎｖ）基因的核酸片段,并对其Ｃ２－Ｖ３及邻区３５０￣４５０个核苷酸序列进行了测定和分析。结果表明,１４份样品中９份为泰国Ｂ（Ｂ＇）亚型,５份为Ｅ亚型毒株。其中Ｂ＇亚型毒株的基因离散率为４．２％,与Ａ－Ｅ参考亚型及部分Ｂ亚型代表株序列相比较,与包括泰国、缅甸及云南德宏在内的Ｂ亚型毒株序列十     

1995年云南瑞丽HIV1毒株的基因变异和分析

从１９９５年瑞丽静脉注射毒品者及其配偶２６人的血样中,经ＰＣＲ扩增细胞内ＨＩＶ基因并对其ｅｎｖＣ２－Ｖ３区进行测序,结果发现１８人为Ｂ亚型ＨＩＶ１,８人为Ｃ亚型ＨＩＶ１毒株,在瑞丽以Ｂ亚型毒株为主,与我们以往报告一致,Ｃ亚型毒株的出现曾有报告,我们进一步分析发现,Ｃ亚型毒株感染者多在１９９４和１９９５年被感染,根据其核苷酸序列测定的基因离散率（２．２５％）,远小于Ｂ型毒株（６．７％）,也说明它是近     

人类免疫缺陷病毒膜蛋白基因（env）F亚型毒株在中国的首例发现

１９９８年广东某戒毒所ＨＩＶ阳性感染者的血样,经ＰＣＲ扩增未培养细胞内ＨＩＶ前病毒基因并对Ｃ２－Ｖ３区进行测序和分析,发现两例感染者与巴西Ｆ亚型毒株ＢＺ１６３的基因离散率小于４％;Ｎｅｉｇｈｂｏｒ－ｊｏｉｎｉｎｇ系统树表明,它们与Ｆ亚型聚在一起;通过异源双链泳动技术分析法（ＨＭＡ）分析,这两例感染者与Ｆ亚型形成明显的异源二聚体。上述各项研究结果表明,Ｆ亚型ＨＩＶ－１已传入我国。     

HIV—1抗体阳性血浆中HIV—1病毒基因分型研究

为了解ＨＩＶ抗体阳性血浆中的ＨＩＶ１病毒基因亚型的情况,应用逆转录ＰＣＲ和ＤＮＡ序列测定技术,对６份获自高危人群的抗ＨＩＶ１阳性血浆进行序列分析和基因亚型分型的研究,结果表明均属ＨＩＶ１Ｂ亚型。Ｖ３环氨基酸序列分析指出这些ＨＩＶ１Ｂ亚型病毒株与泰国ＨＩＶ１Ｂ亚型病毒株核苷酸和氨基酸序列相似;同时发现ＨＩＶ１ｃＤＮＡ和氨基酸序列均相同,推测这６份标本可能来自同时感染同一株ＨＩＶ病毒的感染者。本研究对了解高危人群中ＨＩＶ１流行的遗传变异和ＨＩＶ１亚型病毒株的分子流行病分析具有一定的意义。     

应用异源双链泳动分析法快速确定(HIV-1)基因亚型

应用异源双链泳动分析法（Ｈｅｔｅｒｏｕｄｕｐｌｅｘ ｍｏｂｉｌｉｔｙ ａｓｓａｙ,ＨＭＡ）,对来自我国云南、四川、新疆、浙江、广东、福建、天津７省市７３份ＨＩＶ感染者样品,进行了ＨＩＶ－１膜蛋白（ｅｎｖ）基因片段亚型分析。通过ＨＭＡ能确定亚的有７０份,占样品总数的９５．８９％（７０／７２）。其中Ａ亚型２．８６％（２／７０）,Ｆ亚型２．８６％（２／７０）,泰国Ｂ亚型１８．５８％（１３／７０）,欧美Ｂ     

1992—1994年HIV—1国际流行株和云南株膜蛋白V3区氨基酸共有序列比较

对１９９２～１９９４年间１６个云南ＨＩＶ１株膜蛋白基因Ｖ３区进行了ＤＮＡ序列测定,经计算机ＤＮＡＳＩＳ及ＰＲＯＳＩＳ软件进行同源性分析,得出其相应的氨基酸共有序列ＹＮＶ３和两组共有序列ＹＮＶ３Ａ和ＹＮＶ３Ｂ,计算了ＹＮＶ３中每个氨基酸的保守性。分别将ＹＮＶ３Ａ和ＹＮＶ３Ｂ与世界各地的ＨＩＶ１代表株的相应序列进行了同源性比较。结果表明,ＨＩＶ１云南株膜蛋白Ｖ３区氨基酸共有序列ＹＮＶ３中每个氨基酸的平均变异度为７．６６％。两组共有序列ＹＮＶ３Ａ和ＹＮＶ３Ｂ,分别与ＨＩＶ１美欧株及泰国流行株Ｂ亚群相应序列有较高同源性。这一结果提示,在进化上云南瑞丽ＨＩＶ１流行毒株间有非常密切的关系,在这一时期该地区的流行毒株以ＨＩＶ１美欧株、泰国株Ｂ亚群及其衍生株为主。     

中国不同地区和人群HDV cDNA的筛选、克隆及抗原编码区基因异质性的分析

为研究我国不同地区不同人群中ＨＤＶ毒株的感染分子特征,从我国河南、内蒙、北京、四川、广西、西藏、新疆、辽宁、上海等地的ＨＤＶ健康携带者、慢性丁肝病人与重症肝炎病人中筛选获得１０余份ＨＤＶ－ＲＮＡ阳性血清。经逆转录一多聚酶链反应（ＲＴ－ＰＣＲ）交叉扩增获得ＨＤＶ抗原编码区的ｃＤＮＡ片段并克隆到ＰＧＥＭ－３Ｚｆ（－）或ＰＧＥＭ－Ｔ载体上,经序列分析研究其基因结构特点,结果表明：中国的ＨＤＶ毒株基因型均为Ⅰ型,但至少存在ⅠＡ、ⅠＢ两个亚型,ＨＤＶ毒株在不同地区间存在异质性,其中河南－１、－２、－３株及新疆株与台湾株同源性较高（核苷酸与氨基酸同源性分别大于９２．１％与８６．９％）．当为ⅠＡ型;内蒙－１、四川、广西、西藏－１、辽宁、北京株与美国－１株同源性较高（核苷酸与氨酸同源性分别大于９４．３％与８８．８％）,当为ⅠＢ亚型;上海株与意大利株的核昔酸同源性最高,为９８．１％。研究证明我国新疆、内蒙、西藏等地区抗ＨＤ阳性率比其他省市高并不是由于存在其他基因型所致。     

传染性法氏囊病病毒中国强毒株A节段cDNA基因的克隆和序列分析

以来自哈尔滨传染性法氏囊病病毒（ＩＢＤＶ） 强毒株（Ｈａｒｂｉｎ 毒株,Ｈ） 的基因组ＲＮＡ为模板,用反转录聚合酶链反应（ＲＴ－ ＰＣＲ） 的方法得到了其Ａ 节段的全长ｃＤＮＡ 片段,分５＇端（１ ６５９ｂｐ） 和３＇端（１ ４４４ｂｐ） 上下两段分别克隆到ｐＧＥＭＢ○Ｒ － Ｔ 载体上,测定了其核苷酸顺序,在长为３ １０１ ｂｐ 中含有两个阅读框ＯＲＦＡ１ 和ＯＲＦＡ２ ,分别编码１ ０１２ 个氨基酸的前体蛋白（ＶＰ２ － ４ －３） 和１４５ 个氨基酸的ＶＰ５,ＯＲＦＡ１ 和ＯＲＦＡ２ 有部分的重叠。将核苷酸序列及推测出的氨基酸序列与已报道的ＩＢＤＶ 血清Ⅰ型和Ⅱ型毒株的相应序列进行了比较,结果表明：Ｈ 毒株与其它血清Ⅰ型毒株之间,在核苷酸水平上存在２５ｂｐ － ２６７ｂｐ 的差异;在氨基酸水平上存在１７ ～４０ 个氨基酸的差异。在ＶＰ２ － ４ － ３ 内比较显示,Ｈ 毒株与Ｐ２ 、Ｃｕ－ １ 之间氨基酸的差异最小为１ ．７％ ,Ｈ 毒株与ＵＫ６６１ 之间氨基酸的差异最大为３ ．９ ％ 。变异主要发生在ＶＰ２ 的可变区（２０６ － ３５０ 位氨基酸） ,在Ｈ 毒株所特有的１２ 个氨基酸当中,该区就占５ 个,代表１ ．７６ ％ 的变异。ＶＰ４、ＶＰ３ 和ＶＰ５区各有     

人工合成多肽检测抗HIV－1和HIV－2抗体的研究

采用固相法合成ＨＩＶ－１和ＨＩＶ－２两个多肽,建立了用混合多肽为包被抗原检测ＨＩＶ－１和ＨＩＶ－２感染的间接酶联免疫吸附法。检测４６份抗ＨＩＶ－１和ＨＩＶ－２抗体阳性血清标本以及９４份对照血清标本,与ＵＢＩ试剂比较,其阳性符合率为９７．８％,阴性符合率为１００％,总符合率为９９．３％。实验结果表明,此法可用于ＨＩＶ－１和ＨＩＶ－２感染的检测。     

中国HIV-1流行毒株的DNA疫苗的初步研究

为研制针对我国ＨＩＶ－１流行毒株的艾滋病毒疫苗,构建了具有代表性的ｇａｇ和ｇｐ１２０核酸疫苗,进行了初步的小鼠免疫实验。结果初步显示：（１）免疫Ｂａｌｂ／Ｃ小鼠可以产生ＨＩＶ－１特异性的体液和细胞免疫;（２）ｇａｇ和ｇｐ１２０基因联合免疫可以同时诱发针对ｇａｇ和ｇｐ１２０的细胞和体液免疫反应,而且效果比各自单独免疫要好;（３）Ｂ亚型ｇｐ１２０基因免疫可以诱发识别Ｃ亚型ｇｐ１２０抗原的ＣＴＬ反应。本     

新疆乌鲁木齐HIV—1流行毒株膜蛋白基因C2—V3区序列测定和亚型分析

应用ＰＣＲ方法对７份１９９６年３－５月采集于新疆乌鲁木齐ＨＩＶ－１阳性静脉吸毒者的外周血单核细胞样品进行扩增,获得了ＨＩＶ－１膜蛋白基因的核酸片段,并对其Ｃ２－Ｖ３区及邻区３５０－４５０个核苷酸序列进行了测定和分析。     

河南郑州市男男同性恋HIV-1感染者gag区基因亚型分析

为了解河南郑州市男男同性恋人群HIV-1流行株的亚型分布情况,运用反转录及套式PCR方法从40例已经被确认为HIV-1阳性的MSM的全血样本中扩增gag全长基因并进行序列测定,应用BioEdit软件对序列进行校对编辑,利用MEGA3.1软件构件系统进化树,同时使用美国Los Alamos国家实验室HIV核酸序列库和美国NCBI提供的在线分析工具进行比对分析,确定基因亚型。结果成功获得24条gag基因序列,亚型分析结果显示,共存在B、CRF01-AE和CRF07-BC三种亚型,其中B亚型8例（33.33﹪）,CRF01-AE亚型10例（41.67﹪）,CRF07-BC亚型6例（25﹪）。小样本量的流行病学调查显示,河南郑州市同性恋人群中主要存在B,CRF01-AE和CRF07-BC三种亚型,CRF01-AE已成为河南郑州市MSM人群中HIV主要流行亚型,河南地区重组型毒株逐渐占优势,流行情况更加复杂。     

Amino acid sequence divergence of Tat protein (exon1)of subtype B and C HIV-1 strains: Does it have implications for vaccine development?

Functional genes of HIV-1 like the tat express proteins essential for viral survival and propagation. There are variations reported in levels of Tat transactivation among the different subtypes of HIV-1. This study looked at the amino acid differences in the different regions of Tat protein (exon 1) of subtype B and C strains of HIV-1 and tried to observe a molecular basis for protein function. HIV-1 sequences of subtype B (n=30) and C (n=60) strains were downloaded from HIV-1 Los Alamos data base. Among the 60 subtype C strain sequences, 30 each were from India and Africa. A HIV-1 Tat protein (exon 1) sequence, the consensus B and C sequence was obtained from the 'sequence search interface' in the Los Alamos HIV-1 sequence data. The sequences were visualized using Weblogo and the RNA binding regions of the three consensus sequences were also determined using BindN software program. Compared to subtype B, there was a high level of divergence in the auxiliary domain of tat exon 1 (amino acid positions 58- 69). The net charge of the subtype C (Indian) Tat protein (exon 1) auxiliary domain was -1.9 at pH 7 and it had an isoelectric point of 4.1. The net charge of the subtype C (African) auxiliary domain was -2.9 at pH 7 and it had an isoelectric point of 3.7 while the net charge of same region in subtype B was -0.9 at pH 7 with an isoelectric point of 4.9. The ratio of the hydrophilic residues to the total number of residues was 60% in the in both the Indian and African subtype C in the auxiliary domain while this was 50% in subtype B. The consensus subtype B sequence was found to have 36 RNA binding sites while subtype C (India) had 33 and subtype C (Africa) had 32 RNA binding sites. The HIV-1 Tat-TAR interaction is a potential target for inhibitors and being considered for its potential use in HIV-1 vaccines. Development of such inhibitor/vaccines would have to take into consideration the variation in amino acid sequence analyzed in this study as this could determine epitope presentation on MHC class I antigen for afferent immune response.     

Phenotypic and genotypic characteristics of human immunodeficiency virus type 1 from patients with AIDS in northern Thailand.

Primary human immunodeficiency virus type 1 (HIV-1) isolates were obtained from 22 patients with AIDS from northern Thailand, where HIV-1 is transmitted primarily through the heterosexual route. Viral sequences were determined for the 22 patients with AIDS, and all were subtype E HIV-1 on the basis of sequence analysis of a region from the envelope protein gp120. Syncytium-inducing (SI) viruses were detected for 16 of 22 patients with AIDS by using MT-2 cells. Characteristics of amino acid sequences in V3 which have not been reported previously for subtype B SI HIV-1 were associated with the subtype E HIV-1 SI phenotype. The SI viruses from our study population contain predominantly a GPGR or GPGH motif at the tip of the V3 loop, in contrast to the previously described subtype E HIV-1 from Thailand which contained predominantly GPGQ. All the SI viruses lost a potential N-linked glycosylation site in V3 which is highly conserved among previously described subtype E HIV-1 isolates from asymptomatic patients from Thailand. HIV-1 envelope sequences including V3 from some patients with AIDS were significantly more divergent than viruses from asymptomatic patients in Thailand characterized 2 years ago or earlier. These results suggest that emergence of subtype E SI HIV-1 variants is associated with the development of AIDS, as it is for subtype B HIV-1. The divergence of subtype E HIV-1 in patients with AIDS as the disease progresses, and the divergence of subtype E HIV-1 in the infected population as the epidemic continues in Thailand, may have important implications for vaccine development.     

A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon.

A new subtype (MVP-5180) of human immunodeficiency virus type 1 (HIV-1) was isolated from a Cameroonian AIDS patient. MVP-5180 was grown in several human T-cell lines and the monocytic U937 line. MVP-5180 DNA could not be amplified by nested primer PCR with conventional env primers and could be only very faintly amplified with gag and pol primers. Most German, Ivoirian, and Malawian anti-HIV-1 sera reacted faintly or moderately with Env proteins in an MVP-5180 immunoblot, whereas some Cameroonian sera reacted strongly. Of HIV-1-infected Cameroonians, 8% were identified by serological methods as infected with MVP-5180; 7% were positive when MVP-5180-specific PCR env primers were used. DNA sequence analysis of MVP-5180 showed that its genetic organization was that of HIV-1, with 65% similarity to HIV-1 and 56% similarity to HIV-2 consensus sequences. The env gene of MVP-5180 had similarities to HIV-1 and HIV-2 of 53 and of 49%, respectively. V3 loop analysis identified a crown of Gly-Pro-Met-Arg by using cloned DNA and Gly-Pro-Leu-Arg by using PCR-amplified DNA, neither of which configuration has been described for other HIV strains. In an analysis of relationships, MVP-5180 occupied a position distant to all other HIV-1 strains, including the chimpanzee simian immunodeficiency virus type 1 SIVcpz and the Uganda virus U455, and closer to the HIV-1/HIV-2 divergence node. MVP-5180, together with another Cameroonian isolate, ANT-70, constitutes a group subtype O of the most divergent HIV-1 isolates yet identified. Characterization of MVP-5180 is important for understanding the natural history of the primate immunodeficiency viruses and for the development of vaccines and diagnostics.